Canaccord Genuity Remains a Buy on Alphatec Holdings (ATEC)

Canaccord Genuity analyst Caitlin Cronin reiterated a Buy rating on Alphatec Holdings today and set a price target of $25.00.

Claim 70% Off TipRanks Premium

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

Cronin covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Alphatec Holdings, and Stryker. According to TipRanks, Cronin has an average return of 13.4% and a 55.74% success rate on recommended stocks.

In addition to Canaccord Genuity, Alphatec Holdings also received a Buy from TD Cowen’s Josh Jennings in a report issued yesterday. However, on January 7, Stifel Nicolaus maintained a Hold rating on Alphatec Holdings (NASDAQ: ATEC).

Based on Alphatec Holdings’ latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $196.5 million and a GAAP net loss of $28.58 million. In comparison, last year the company earned a revenue of $150.72 million and had a GAAP net loss of $39.62 million

Based on the recent corporate insider activity of 93 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of ATEC in relation to earlier this year. Last month, David R Pelizzon, a Director at ATEC sold 250,000.00 shares for a total of $4,915,000.00.